Genesia Ventures of Japan closed $113 M Fund IV to support Asian seed-stage entrepreneurs
The $113 million final closure of Japan’s Genesia Ventures’ fourth fund, which is intended for seed-stage entrepreneurs in Japan, Southeast Asia, and India, was completed.
Fund IV is mainly supported by institutional investors and financial organizations both domestically and internationally, according to a statement released by Genesia Ventures on Wednesday. The company stated that it intends to concentrate capital more deeply in each portfolio company and be more selective in the amount of investments made compared to earlier funds.
Tokyo, Jakarta, Ho Chi Minh City, and Bengaluru are the locations of Genesia Ventures’ offices. The company focuses on the fundamental causes of structural change rather than defining its investment strategy by specific industry sectors. Healthcare, insurance, renewable energy, supply chain infrastructure, alternative financing, space travel, battery intelligence, and sophisticated materials are just a few of the industries covered by its portfolio.
Founder and general partner Soichi Tajima stated that the company will invest more extensively in each business while being more discriminating about how many investments it made.
“We will continue backing founders operating at the intersection of transformational changes and pursuing opportunities with the potential to create significant societal impact,” he said.
Takahiro Suzuki, Head of Overseas Investments and General Partner, said advances in AI, energy transition, and Asia’s economic rise were removing long-standing barriers to industrial progress at unprecedented speed. “I strongly believe this is an era in which startups have expanding opportunities to create major businesses and industries,” he said.
Vietnam is still one of Genesia Ventures’ most important Southeast Asian strategic markets. The company has supported a number of Vietnam-based companies, such as Fundiin, an alternative credit infrastructure company, KAMEREO, a food procurement infrastructure platform, and Buymed, a pharmaceutical distribution infrastructure company.
Additionally, the company created Genesia Orbit Vietnam, a founder development platform that provides early-stage entrepreneurs in the nation with workshops, knowledge-sharing initiatives, and cross-border community events.
Among the company’s significant exits were Timee’s July 2024 IPO on the Tokyo Stock Exchange Growth Market and HRBrain’s November 2023 secondary exit to the European investment fund EQT. Docquity, a doctor platform that operates in seven countries, and Qoala, an insurance solutions platform that operates in five countries, are two examples of Southeast Asian portfolio firms.
